Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4f8755c361b70eb6af66fd6a114e590 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-914 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y306-05005 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y306-05005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2014-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2aa8d3f3dabacf60bff3abdc793a7c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff88fa8afe058c9b42ba0f2755950eb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_964a4472caef5aa867fc48b04f204485 |
publicationDate |
2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016264976-A1 |
titleOfInvention |
Dynamin 2 inhibitor for the treatment of centronuclear myopathies |
abstract |
The present disclosure relates to an inhibitor of Dynamin 2 for use in the treatment of centronuclear myopathies. The present disclosure relates to pharmaceutical compositions containing Dynamin 2 inhibitor and to their use for the treatment of centronuclear myopathies. It also deals with a method for identifying or screening molecules useful in the treatment of a centronuclear myopathy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666628-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787869-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019092251-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114007635-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019309305-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020028844-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679161-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10947540-B2 |
priorityDate |
2013-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |